NANJING, China, June 8 /PRNewswire-FirstCall/ -- Simcere Pharmaceutical Group , a leading manufacturer and supplier of branded generic pharmaceuticals in the rapidly growing Chinese marketplace, announced today that it will deliver a presentation at the Goldman Sachs 28th Annual Global Healthcare Conference on June 13, 2007. Simcere’s Chief Executive Officer, Mr. Jinsheng Ren, is scheduled to present at approximately 2:40 p.m. Pacific Time.
A live webcast of the presentation will be available on the investor relations portion of Company’s Web site, located at http://www.simcere.com.
About Simcere Pharmaceutical Group
Simcere Pharmaceutical Group is a leading manufacturer and supplier of branded generic pharmaceuticals in the rapidly growing China market. It currently manufactures and sells 35 pharmaceutical products including antibiotics, anti-cancer medication and anti-stroke medication and is the exclusive distributor of three additional pharmaceuticals that are marketed under its brand names. Simcere concentrates its research and development efforts on the treatment of diseases with high incidence and/or mortality rates and for which there is a clear demand for more effective pharmacotherapy such as cancer, strokes, osteoporosis and infectious diseases. For more information about Simcere Pharmaceutical Group, please visit http://www.simcere.com.
Simcere Pharmaceutical Group
CONTACT: In China, Eric Wang Lam Cheung, Vice President, InvestorRelations of Simcere Pharmaceutical Group, +86-25-8556-6666 x8898,eric.cheung@simcere.com; or In the United States, Ashley Zandy of BrunswickGroup LLC, +1-212-333-3810, ir@simcere.com, for Simcere PharmaceuticalGroup
Web site: http://www.simcere.com/
